477.7K XNAS Volume
XNAS 20 Mar, 2025 2:22 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 24,289 | 24,289 | - | - | Performance RSUs | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 48,579 | 576,815 | - | 0 | Common Stock | |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 3,687 | 537,833 | - | 12.5 | 45,977 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 4,198 | 533,635 | - | 12.5 | 52,349 | Common Stock |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 5,399 | 528,236 | - | 12.5 | 67,326 | Common Stock |
| Alexander Dimitrief | SVP, General Counsel and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 8,211 | 278,672 | - | 12.5 | 102,391 | Common Stock, $0.01 par value per share ("Common Stock") |
| Alexander Dimitrief | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 56,053 | 334,725 | - | 0 | Common Stock | |
| Alexander Dimitrief | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 28,026 | 28,026 | - | - | Performance RSUs | |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 149,476 | 149,476 | - | - | Performance Stock Units | |
| Michael B. Petras | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 27,990 | 642,509 | - | 12.5 | 349,035 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 31,872 | 610,637 | - | 12.5 | 397,444 | Common Stock |
| Michael B. Petras | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 40,987 | 569,650 | - | 12.5 | 511,108 | Common Stock |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 298,953 | 868,603 | - | 0 | Common Stock | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 29,895 | 29,895 | - | - | Performance RSUs | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 37,369 | 201,110 | - | 0 | Common Stock | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 59,790 | 163,741 | - | 0 | Common Stock | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 02 Mar 2025 | 6,481 | 103,951 | - | 12.5 | 80,818 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.21 per share. | 20 Nov 2024 | 2,889 | 541,520 | - | 13.2 | 38,164 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2024 | 39,243 | 39,243 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2024 | 39,243 | 5,214,337 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.21 per share. | 20 Nov 2024 | 29,250 | 670,499 | - | 13.2 | 386,393 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Sep 2024 | 200,000 | 5,253,580 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.22 per share. | 05 Aug 2024 | 7,659 | 110,432 | - | 14.2 | 108,911 | Common Stock, $0.01 par value per share ("Common Stock") |
| James C. Neary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 61,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Vincent K. Petrella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 61,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David A. Donnini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 61,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 20,089 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ruoxi Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 61,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ann R. Klee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 106,824 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 55,780 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Sean L. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 61,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Constantine S. Mihas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 61,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Robert B. Knauss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 35,801 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Alexander Dimitrief | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 102,095 | 102,095 | - | - | Stock Options | |
| Alexander Dimitrief | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 51,405 | 286,883 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ann R. Klee | Director | Sale of securities on an exchange or to another person at price $ 14.31 per share. | 04 Mar 2024 | 5,750 | 86,735 | - | 14.3 | 82,268 | Common Stock, $0.01 par value per share ("Common Stock") |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 41,124 | 118,091 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 81,676 | 81,676 | - | - | Stock Options | |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.56 per share. | 02 Mar 2024 | 2,438 | 596,311 | - | 14.6 | 35,497 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.56 per share. | 02 Mar 2024 | 3,063 | 593,248 | - | 14.6 | 44,597 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 34,270 | 627,518 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael P. Rutz | President of Sterigenics | Sale of securities on an exchange or to another person at price $ 14.31 per share. | 02 Mar 2024 | 83,109 | 544,409 | - | 14.3 | 1,189,082 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 68,063 | 68,063 | - | - | Stock Options | |
| Michael B. Petras | Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.56 per share. | 02 Mar 2024 | 27,990 | 447,163 | - | 14.6 | 407,534 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.56 per share. | 02 Mar 2024 | 21,574 | 425,589 | - | 14.6 | 314,117 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 274,160 | 699,749 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Chairman & CEO | Sale of securities on an exchange or to another person at price $ 14.31 per share. | 02 Mar 2024 | 1,003,870 | 5,453,580 | - | 14.3 | 14,362,870 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 544,509 | 544,509 | - | - | Stock Options | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 33,640 | 33,640 | - | - | Stock Options | |
| Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 76,967 | 76,967 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| James C. Neary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 41,560 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Vincent K. Petrella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 41,560 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| David A. Donnini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 41,560 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Ruoxi Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 41,560 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Ann R. Klee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 92,485 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 35,691 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Sean L. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 41,560 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Constantine S. Mihas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 41,560 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Robert B. Knauss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 15,712 | 15,712 | - | 0 | Common Stock, $0.01 par value per share (Common Stock) | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 53,879 | 53,879 | - | - | Stock Options | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 28,425 | 600,660 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 404,094 | 404,094 | - | - | Stock Options | |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 213,189 | 584,668 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.41 per share. | 02 Mar 2023 | 2,948 | 572,235 | - | 17.4 | 51,325 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.41 per share. | 02 Mar 2023 | 19,841 | 371,479 | - | 17.4 | 345,432 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.02 per share. | 20 Nov 2022 | 1,911 | 575,183 | - | 6.0 | 11,504 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.02 per share. | 20 Nov 2022 | 29,251 | 391,320 | - | 6.0 | 176,091 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 2,108,356 | 2,108,356 | - | - | Stock Options | |
| James C. Neary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Vincent K. Petrella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David A. Donnini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ruoxi Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ann R. Klee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 76,773 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 19,979 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Sean L. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Stephanie M. Geveda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Constantine S. Mihas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,643 | 25,848 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 63,857 | 63,857 | - | - | Stock Options | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 24,962 | 577,094 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Terrence G. Hammons | SVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 57,471 | 57,471 | - | - | Stock Options | |
| Terrence G. Hammons | SVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 22,466 | 31,257 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 478,932 | 478,932 | - | - | Stock Options | |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 187,219 | 420,571 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 37,443 | 738,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 95,786 | 95,786 | - | - | Stock Options | |
| Michael P. Rutz | President of Sterigenics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.54 per share. | 20 Nov 2021 | 1,911 | 552,132 | - | 22.5 | 43,074 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.54 per share. | 20 Nov 2021 | 27,517 | 233,352 | - | 22.5 | 620,233 | Common Stock, $0.01 par value per share ("Common Stock") |
| Scott J. Leffler | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.54 per share. | 20 Nov 2021 | 3,894 | 701,206 | - | 22.5 | 87,771 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael P. Rutz | President of Sterigenics | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 25 Aug 2021 | 67,000 | 554,043 | - | 25.0 | 1,676,876 | Common Stock, $0.01 par value per share ("Common Stock") |
| James C. Neary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Vincent K. Petrella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David A. Donnini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ruoxi Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ann R. Klee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 66,130 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David E. Wheadon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 9,336 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Sean L. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Stephanie Geveda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Constantine S. Mihas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 9,336 | 15,205 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Matthew J. Klaben | SVP, GC and Secretary | Sale of securities on an exchange or to another person at price $ 26.12 per share. | 22 Mar 2021 | 41,952 | 327,286 | - | 26.1 | 1,095,891 | Common Stock, $0.01 par value per share ("Common Stock") |
| Michael B. Petras | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 26.12 per share. | 22 Mar 2021 | 817,439 | 6,377,185 | - | 26.1 | 21,353,550 | Common Stock, $0.01 par value per share ("Common Stock") |
| James C. Neary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Matthew J. Klaben | SVP, GC and Secretary | Sale or transfer of securities back to the company at price $ 21.68 per share. | 20 Nov 2020 | 69,196 | 369,238 | - | 21.7 | 1,500,169 | Common Stock |
| Matthew J. Klaben | SVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 134,161 | 134,161 | - | - | Stock Options | |
| Matthew J. Klaben | SVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 31,304 | 31,304 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Vincent K. Petrella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| David A. Donnini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 26,086 | 621,043 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael P. Rutz | President of Sterigenics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 111,801 | 111,801 | - | - | Stock Options | |
| Ruoxi Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Ann R. Klee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 56,794 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 260,869 | 260,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Michael B. Petras | Director, Chairman & CEO | Sale or transfer of securities back to the company at price $ 21.68 per share. | 20 Nov 2020 | 437,821 | 0 | - | 21.7 | 9,491,959 | Common Stock |
| Michael B. Petras | Director, Chairman & CEO | Sale or transfer of securities back to the company at price $ 21.68 per share. | 20 Nov 2020 | 946,102 | 7,194,624 | - | 21.7 | 20,511,491 | Common Stock |
| Michael B. Petras | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 1,118,012 | 1,118,012 | - | - | Stock Options | |
| Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 223,602 | 223,602 | - | - | Stock Options | |
| Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 52,173 | 820,426 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Scott J. Leffler | CFO and Treasurer | Sale or transfer of securities back to the company at price $ 21.68 per share. | 20 Nov 2020 | 115,326 | 705,100 | - | 21.7 | 2,500,268 | Common Stock |
| Sean L. Cunningham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Stephanie Geveda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Constantine S. Mihas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 5,869 | 5,869 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") |